Histamine and histamine receptor regulation of gastrointestinal cancers.

Histamine is a neurotransmitter released throughout the body that regulates multiple physiological responses. Primarily histamine is acknowledged for its role in inflammatory reactions to foreign pathogens that enter the body. Aside from inflammatory responses, histamine expression and synthesis has been detected in various cancer cell lines and multiple malignancies. Through experimentation histamine has demonstrated its ability to manage proliferation and angiogenesis in these cancerous cells, in either a positive or inhibitory manner. Regulation of angiogenesis and proliferation have been proven to be carried out by the stimulation or inhibition of numerous pathways and secondary response elements, such as VEGFA/C, IP3/Ca2+, G-proteins, cAMP, and many more. The activation of these different response pathways is linked to the binding of ligands to the histamine receptors H1-H4HR. These receptors exhibit various effects dependent on whether it binds an agonist, antagonist, or its specific ligand, histamine. In cancer cell lines and different tumor cells the binding of these different compounds has shown to be one of the main components in exerting proliferative or antiproliferative changes in the microenvironment. It is also known that the histamine receptors have varying degrees of expression in different forms of cancer, and this expression can impact the tumor in various ways. This clearly indicates the significance of histamine receptors in cancer formation, and one of the aims of this review is to cover this topic concisely and in depth. Histamine is produced from numerous cells such as basophils and mast cells and is synthesized from the enzyme histidine decarboxylase (HDC). In this review we will prominently discuss the function of mast cells and HDC in histamine expression in various gastrointestinal carcinomas. We also briefly discuss current studies to support these claims. In this review we hope to give the reader a clear and comprehensible overview of histamine in various gastrointestinal cancers, and how its regulation can affect the cancer cells in varying ways.

[1]  K. Okoń,et al.  Mast cells and cancer: enemies or allies? , 2012, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[2]  Ilseung Cho,et al.  Infectious causes of colorectal cancer. , 2010, Infectious disease clinics of North America.

[3]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[4]  E. Lilius,et al.  Histamine receptors on leukocytes are expressed differently in vitro and ex vivo. , 1990, International archives of allergy and applied immunology.

[5]  Yuchen Jiao,et al.  ATM mutations in patients with hereditary pancreatic cancer. , 2012, Cancer discovery.

[6]  Y. Sasaguri,et al.  Histidine decarboxylase expression in pancreatic endocrine cells and related tumors , 2004, Pathology international.

[7]  R. Mancinelli,et al.  Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases. , 2011, The American journal of pathology.

[8]  M. Cervello,et al.  Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells , 2007, Experimental & Molecular Medicine.

[9]  F. Sundler,et al.  Trophic effects of gastrin. , 1991, Scandinavian journal of gastroenterology. Supplement.

[10]  Jinzhong Liu,et al.  Expression of non‐mast cell histidine decarboxylase in tumor‐associated microvessels in human esophageal squamous cell carcinomas   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  M. Boyano,et al.  Histamine and histamine receptor antagonists in cancer biology. , 2010, Inflammation & allergy drug targets.

[12]  A. Franchitto,et al.  Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes. , 2010, World journal of gastrointestinal pathophysiology.

[13]  T. Starzl,et al.  Cell proliferation and oncogene expression after bile duct ligation in the rat: Evidence of a specific growth effect on bile duct cells , 1995, Hepatology.

[14]  C. M. Davenport,et al.  Cloning, expression, and pharmacological characterization of a novel human histamine receptor. , 2001, Molecular pharmacology.

[15]  S. Glaser,et al.  Cholangiocyte proliferation and liver fibrosis , 2009, Expert Reviews in Molecular Medicine.

[16]  R. Mancinelli,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology After Damage of Large Bile Ducts by Gamma-Aminobutyric Acid , Small Ducts Replenish the Biliary Tree by Amplification of Calcium-Dependent Signaling and de Novo Acquisition of Large Cholangiocyte Phenotypes , 2010 .

[17]  P. Rangachari Histamine: mercurial messenger in the gut. , 1992, The American journal of physiology.

[18]  R. Seifert,et al.  Systematic analysis of histamine and N-methylhistamine concentrations in organs from two common laboratory mouse strains: C57Bl/6 and Balb/c , 2011, Inflammation Research.

[19]  R. Mancinelli,et al.  Activation of alpha1‐adrenergic receptors stimulate the growth of small mouse cholangiocytes Via calcium‐dependent activation of nuclear factor of activated T cells 2 and specificity protein 1 , 2011, Hepatology.

[20]  F. Sánchez-Jiménez,et al.  Histamine-mediated signaling processes in human malignant mammary cells , 2006, Cancer biology & therapy.

[21]  Bharati Bapat,et al.  Epigenetic biomarkers in colorectal cancer diagnostics , 2012, Expert review of molecular diagnostics.

[22]  V. Egorov,et al.  Pancreatic adenocarcinoma: Outstanding problems. , 2012, World journal of gastrointestinal surgery.

[23]  M. Koch,et al.  In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction , 2010, Proceedings of the National Academy of Sciences.

[24]  R. Mancinelli,et al.  H3 Histamine Receptor–Mediated Activation of Protein Kinase Cα Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo , 2009, Molecular Cancer Research.

[25]  R. Leurs,et al.  Molecular pharmacology of histamine H4 receptors. , 2012, Frontiers in bioscience.

[26]  F. Genre,et al.  Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors , 2008, Inflammation Research.

[27]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[28]  T. Terada,et al.  Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2000, Journal of hepatology.

[29]  F. Sánchez-Jiménez,et al.  The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. , 2008, Cancer biology & therapy.

[30]  D. Ebo,et al.  Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils. , 2012, Journal of immunological methods.

[31]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[32]  S. Hill,et al.  Distribution, properties, and functional characteristics of three classes of histamine receptor. , 1990, Pharmacological reviews.

[33]  L. Sarkozi,et al.  Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. , 1988, The Journal of clinical investigation.

[34]  C. Gespach,et al.  Histamine interaction on surface recognition sites of H2‐type in parietal and non‐parietal cells isolated from the guinea pig stomach , 1982, FEBS letters.

[35]  P. Desai,et al.  Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[36]  R. Thurmond,et al.  The histamine H4 receptor as a new therapeutic target for inflammation. , 2005, Trends in pharmacological sciences.

[37]  J. Schwartz,et al.  H3‐Receptors Control Histamine Release in Human Brain , 1988, Journal of neurochemistry.

[38]  J. Marshall,et al.  Mast cells in innate immunity. , 2004, The Journal of allergy and clinical immunology.

[39]  S. Jimi,et al.  Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.

[40]  N. LaRusso,et al.  The Pathophysiology of Biliary Epithelia , 2004 .

[41]  S. Glaser,et al.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. , 2007, Gastroenterology.

[42]  W. Schunack,et al.  Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[43]  R. Kiss,et al.  Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review). , 2006, International journal of oncology.

[44]  W. Palmer,et al.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.

[45]  Min Liu,et al.  MicroRNA‐182 targets cAMP‐responsive element‐binding protein 1 and suppresses cell growth in human gastric adenocarcinoma , 2012, The FEBS journal.

[46]  A. Falus,et al.  Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines , 1991, Agents and Actions.

[47]  S. Glaser,et al.  Functional heterogeneity of the intrahepatic biliary epithelium , 2000, Hepatology.

[48]  M. Strazzabosco,et al.  Transport systems in cholangiocytes: their role in bile formation and cholestasis. , 1997, The Yale journal of biology and medicine.

[49]  T. Patel,et al.  Worldwide trends in mortality from biliary tract malignancies , 2002, BMC Cancer.

[50]  C. Prinz,et al.  H pylori and gastric cancer: shifting the global burden. , 2006, World journal of gastroenterology.

[51]  S. Glaser,et al.  Regulation of cholangiocyte bicarbonate secretion. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[52]  Nicholas J. Carruthers,et al.  Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. , 2001, Molecular pharmacology.

[53]  R. Mancinelli,et al.  Taurocholate Feeding to Bile Duct Ligated Rats Prevents Caffeic Acid-Induced Bile Duct Damage by Changes in Cholangiocyte VEGF Expression , 2009, Experimental biology and medicine.

[54]  A. Bado,et al.  Purification of a histamine H3 receptor negatively coupled to phosphoinositide turnover in the human gastric cell line HGT1. , 1992, The Journal of biological chemistry.

[55]  J. Benovic,et al.  Bimodal Regulation of the Human H1 Histamine Receptor by G Protein-coupled Receptor Kinase 2* , 2005, Journal of Biological Chemistry.

[56]  A. Franchitto,et al.  Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. , 2008, American journal of physiology. Cell physiology.

[57]  Erik Svensjö,et al.  Evidence for endothelial cell-mediated regulation of macromolecular permeability by postcapillary venules. , 1986, Federation proceedings.

[58]  H. Haas,et al.  International Union of Pharmacology. XIII. Classification of histamine receptors. , 1997, Pharmacological reviews.

[59]  R. Mancinelli,et al.  Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms , 2012, Laboratory Investigation.

[60]  A. Falus,et al.  Histamine in normal and malignant cell proliferation. , 2010, Advances in experimental medicine and biology.

[61]  E. Theodorsson,et al.  Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation , 1999, Regulatory Peptides.

[62]  A. Falus,et al.  Histamine elevates the expression of Ets‐1, a protooncogen in human melanoma cell lines through H2 receptor , 2005, FEBS letters.

[63]  J. Venter,et al.  Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma , 2011, Gut.

[64]  A. Falus,et al.  Histamine: an early messenger in inflammatory and immune reactions. , 1992, Immunology today.

[65]  D. Morris,et al.  Cimetidine and colorectal cancer — old drug, new use? , 1995, Nature Medicine.

[66]  G. Martín,et al.  Histamine as an autocrine growth factor: an unusual role for a widespread mediator. , 2000, Seminars in cancer biology.

[67]  D. Parkin,et al.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[68]  W. Schunack,et al.  Epithelial cell proliferation is promoted by the histamine H(3) receptor agonist (R)-alpha-methylhistamine throughout the rat gastrointestinal tract. , 2006, European journal of pharmacology.

[69]  F. Meng,et al.  The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis , 2011, Hepatology.

[70]  S. Glaser,et al.  Knockout of α-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice , 2007, Laboratory Investigation.

[71]  F. Sundler,et al.  Histamine in endocrine cells in the stomach , 2004, Histochemistry.

[72]  M. Kelly,et al.  Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor‐associated lymphocytes , 1999, Cancer.

[73]  V. László,et al.  Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju. , 2004, Anticancer research.

[74]  L. Cronenberger,et al.  Relationship between the multiple forms of rat gastric histidine decarboxylase: effects of conditions favouring phosphorylation and dephosphorylation. , 1990, Biochemistry international.

[75]  S. Glaser,et al.  The α2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats , 2007 .

[76]  M. Micev,et al.  [Pathology and pathobiology of the gastric carcinoma]. , 2011, Acta chirurgica Iugoslavica.

[77]  Vanina A Medina,et al.  Histamine receptors and cancer pharmacology , 2010, British journal of pharmacology.

[78]  G. Kahlson New Approaches to the Physiology of Histamine , 2015, Physiological reviews.

[79]  F. Cianchi,et al.  The Role of Cyclooxygenase-2 in Mediating the Effects of Histamine on Cell Proliferation and Vascular Endothelial Growth Factor Production in Colorectal Cancer , 2005, Clinical Cancer Research.

[80]  P. Greengard,et al.  Pharmacological properties of histamine-sensitive adenylate cyclase from guinea pig cardiac ventricular muscle. , 1979, Molecular pharmacology.

[81]  F. Shenton,et al.  Immunolocalization of histamine H3 receptors on endocrine cells in the rat gastrointestinal tract. , 2008, Histology and histopathology.

[82]  T. Wang,et al.  The regulation of histidine decarboxylase gene expression. , 1996, The Yale journal of biology and medicine.

[83]  F. Sánchez-Jiménez,et al.  The polyamine and histamine metabolic interplay in cancer and chronic inflammation , 2009, Current opinion in clinical nutrition and metabolic care.

[84]  J. Arrang,et al.  Autoregulation of McA-RH7777 Hepatoma Cell Proliferation by Histamine H3 Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.

[85]  A. Falus,et al.  Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly , 2002, Inflammation Research.

[86]  R. Fossmark,et al.  Gastric Carcinomas Localized to the Cardia , 2012, Gastroenterology research and practice.

[87]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[88]  J. Dagorn,et al.  Current Knowledge on Pancreatic Cancer , 2012, Front. Oncol..

[89]  N. LaRusso,et al.  Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. , 1996, Gastroenterology.

[90]  Y. Shiratori,et al.  Cimetidine inhibits epidermal growth factor‐induced cell signaling , 2007, Journal of gastroenterology and hepatology.

[91]  T. Roskams,et al.  Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. , 2005, Gastroenterology.

[92]  O. Pignataro,et al.  Role of histamine H4 receptor in breast cancer cell proliferation. , 2011, Frontiers in bioscience.

[93]  Miao Yu,et al.  Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo. , 2010, Oncology reports.

[94]  F. Labombarda,et al.  Human pancreatic carcinoma cell line Panc-I and the role of histamine in growth regulation , 2000, Inflammation Research.

[95]  F. LaBella,et al.  Displacement of histamine from liver cells and cell components by ligands for cytochromes P450 , 2002, Journal of cellular biochemistry.

[96]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[97]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[98]  S. Glaser,et al.  Autocrine regulation of biliary pathology by activated cholangiocytes. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[99]  S. Patchett,et al.  The Effect of H2 Antagonists on Proliferation and Apoptosis in Human Colorectal Cancer Cell Lines , 2004, Digestive Diseases and Sciences.

[100]  K. Magyar,et al.  Possible regulation of hypothalamus and lung histidine decarboxylase activity by cAMP-dependent protein kinase. , 1991, European journal of biochemistry.

[101]  E. Weber,et al.  Environmental Risk Factors for Chronic Pancreatitis and Pancreatic Cancer , 2011, Digestive Diseases.

[102]  G. Gores,et al.  Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.

[103]  A. Franchitto,et al.  H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway , 2007, Laboratory Investigation.

[104]  H. Meurs,et al.  Role of phosphoinositide metabolism in functional antagonism of airway smooth muscle contraction by beta-adrenoceptor agonists. , 1989, European journal of pharmacology.

[105]  G. Coruzzi,et al.  Role of histamine H4 receptors in the gastrointestinal tract. , 2012, Frontiers in bioscience.

[106]  Lei Shi,et al.  Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression , 2011, BMC Cancer.

[107]  R. Thurmond,et al.  The Histamine H4 Receptor Mediates Allergic Airway Inflammation by Regulating the Activation of CD4+ T Cells , 2006, The Journal of Immunology.

[108]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[109]  C. Gespach,et al.  Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1. , 1983, Life sciences.

[110]  Y. Masuho,et al.  Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes* , 2000, The Journal of Biological Chemistry.

[111]  W. Adams,et al.  Short-course cimetidine and survival with colorectal cancer , 1994, The Lancet.

[112]  Sanjeev Banerjee,et al.  Pancreatic cancer: pathogenesis, prevention and treatment. , 2007, Toxicology and applied pharmacology.

[113]  N. LaRusso,et al.  The pathobiology of biliary epithelia , 2002, Hepatology.

[114]  S. Glaser,et al.  Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[115]  G. Bhagat,et al.  Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells , 2010, Nature Medicine.

[116]  A. Falus,et al.  Autonomous histamine metabolism in human melanoma cells , 2003, Melanoma research.

[117]  G. Martín,et al.  Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells. , 2006, Anticancer research.

[118]  S. Glaser,et al.  Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. , 1996, Gastroenterology.

[119]  S. Glaser,et al.  Bile acid interactions with cholangiocytes. , 2006, World journal of gastroenterology.

[120]  S. Glaser,et al.  Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. , 1997, The American journal of physiology.

[121]  R. Geha,et al.  The H1 histamine receptor regulates allergic lung responses. , 2006, The Journal of clinical investigation.

[122]  S. Glaser,et al.  Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. , 1999, Gastroenterology.

[123]  F. Roviello,et al.  Gastric cancer carcinogenesis and tumor progression. , 2012, Annali italiani di chirurgia.